Header Logo

Connection

Calvin Ho to Interleukin-5

Back to Details
This is a "connection" page, showing publications Calvin Ho has written about Interleukin-5.
Calvin Ho
Connection Strength
0.061
Interleukin-5
  1. Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2025 Nov; 84(11):1888-1899.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.